Your browser doesn't support javascript.
loading
Minor contribution of CYP3A5 to the metabolism of hepatitis C protease inhibitor paritaprevir in vitro.
San, Su Nwe; Matsumoto, Jun; Saito, Yumi; Koike, Masako; Sakaue, Hiroaki; Kato, Yoshinori; Fujiyoshi, Masachika; Ariyoshi, Noritaka; Yamada, Harumi.
Afiliação
  • San SN; a Graduate School of Pharmaceutical Sciences , International University of Health and Welfare , Ohtawara , Japan.
  • Matsumoto J; b Graduate School of Medicine, Dentistry and Pharmaceutical Sciences , Okayama University , Okayama , Japan.
  • Saito Y; c Department of Pharmaceutical Sciences, School of Pharmacy , International University of Health and Welfare , Ohtawara , Japan.
  • Koike M; c Department of Pharmaceutical Sciences, School of Pharmacy , International University of Health and Welfare , Ohtawara , Japan.
  • Sakaue H; d Department of Biochemistry, School of Pharmacy , Tokyo University of Pharmacy and Life Sciences , Tokyo , Japan.
  • Kato Y; c Department of Pharmaceutical Sciences, School of Pharmacy , International University of Health and Welfare , Ohtawara , Japan.
  • Fujiyoshi M; b Graduate School of Medicine, Dentistry and Pharmaceutical Sciences , Okayama University , Okayama , Japan.
  • Ariyoshi N; b Graduate School of Medicine, Dentistry and Pharmaceutical Sciences , Okayama University , Okayama , Japan.
  • Yamada H; a Graduate School of Pharmaceutical Sciences , International University of Health and Welfare , Ohtawara , Japan.
Xenobiotica ; 49(8): 935-944, 2019 Aug.
Article em En | MEDLINE | ID: mdl-30227770
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores de Proteases / Hepacivirus / Compostos Macrocíclicos / Citocromo P-450 CYP3A Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores de Proteases / Hepacivirus / Compostos Macrocíclicos / Citocromo P-450 CYP3A Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article